Propionibacterium acnes endophthalmitis requiring intraocular lens removal after failure of medical therapy.

A 52-year-old Saudi man developed intraocular inflammation 7 weeks after uneventful phacoemulsification with implantation of a silicone posterior chamber intraocular lens (IOL). Cultures from the aqueous and vitreous were repeatedly negative, but a temporary response to intracameral and intravitreal injection of vancomycin was noted. A series of 6 intraocular injections given over 5 days failed to resolve the inflammation. It did, however, disappear after the IOL was removed. The IOL provided the only positive culture in this case of Propionibacterium acnes endophthalmitis. Nine months later, a posterior chamber poly(methyl methacrylate) IOL was implanted. Eighteen months later, the patient had no recurrences. He regained a visual acuity of 20/30, corresponding to his best postoperative result.
AuthorsK D Teichmann
JournalJournal of cataract and refractive surgery (J Cataract Refract Surg) Vol. 26 Issue 7 Pg. 1085-8 (Jul 2000) ISSN: 0886-3350 [Print] UNITED STATES
PMID10946205 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Vancomycin
  • Anti-Bacterial Agents (therapeutic use)
  • Device Removal
  • Endophthalmitis (drug therapy, microbiology, surgery)
  • Eye Infections, Bacterial (drug therapy, etiology, surgery)
  • Gram-Positive Bacterial Infections (drug therapy, etiology, surgery)
  • Humans
  • Lens Implantation, Intraocular
  • Lenses, Intraocular (adverse effects)
  • Male
  • Middle Aged
  • Phacoemulsification
  • Propionibacterium acnes (isolation & purification)
  • Prosthesis-Related Infections (drug therapy, microbiology, surgery)
  • Reoperation
  • Vancomycin (administration & dosage)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: